Evidence map›Paper›PMID 16771850›Full record

ArticleImmunology2006

Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor.

Isabelle G De Plaen, Xin-Bing Han, Xueli Liu, Wei Hsueh, Sankar Ghosh, Michael J May

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Developmental and sexual dimorphic atlas of the prenatal mouse external genitalia at the single-cell level.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Isabelle G De PlaenDepartment of Pediatrics (Neonatology), Children's Memorial Hospital, Northwestern University Medical School, Chicago, IL 60614, USA. isabelledp@northwestern.edu
Xin-Bing Han
Xueli Liu
Wei Hsueh
Sankar Ghosh
Michael J May
Northwestern Memorial Hospital · USNorthwestern University · USUniversity of Pennsylvania · USYale University · US

Funding

Mechanisms of acute bowel injury Role of NF-KBK08HD044558 · NICHD · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI DE PLAEN, ISABELLE G · 2004 to 2008
$645k
NICHD NIH HHS 5K08HD044558NICHD NIH HHS K08 HD044558
6 · The paper itself

Abstract

CXCL2 (macrophage inflammatory protein-2 (MIP-2)), a critical chemokine for neutrophils, has been shown to be produced in the rat intestine in response to platelet-activating factor (PAF) and to mediate intestinal inflammation and injury. The intestinal epithelium, constantly exposed to bacterial products, is the first line of defence against micro-organisms. It has been reported that enterocytes produce proinflammatory mediators, including tumour necrosis factor (TNF) and PAF, and we showed that lipopolysaccharide (LPS) and TNF activate nuclear factor (NF)-kappaB in enterocytes. However, it remains elusive whether enterocytes release CXCL2 in response to LPS and TNF via a NF-kappaB-dependent pathway and whether this involves the endogenous production of TNF and PAF. In this study, we found that TNF and LPS markedly induced CXCL2 gene expression in IEC-6 cells, TNF within 30 min, peaking at 45 min, while LPS more slowly, peaking after 2 hr. TNF- and LPS- induced CXCL2 gene expression and protein release were completely blocked by pyrrolidine dithiocarbamate (PDTC) and helenalin, two potent NF-kappaB inhibitors. NEMO-binding domain peptide, a specific inhibitor of inhibitor protein kappaB kinase (IKK) activation, a major upstream kinase mediating NF-kappaB activation, significantly blocked CXCL2 gene expression and protein release induced by LPS. WEB2170 (PAF antagonist) and anti-TNF antibodies had no effect on LPS-induced CXCL2 expression. In conclusion, CXCL2 gene is expressed in enterocytes in response to both TNF and LPS. LPS-induced CXCL2 expression is dependent on NF-kappaB activation via the IKK pathway. The effect of LPS is independent of endogenous TNF and PAF.

Indexed as

AnimalsAzepinesCell LineChemokine CXCL2Chemokines, CXCDose-Response Relationship, ImmunologicElectrophoretic Mobility Shift AssayEnterocytesGene Expression RegulationI-kappa B ProteinsLipopolysaccharidesNF-kappa BNF-KappaB Inhibitor alphaPlatelet Activating FactorPyrrolidinesRatsAzepinesbepafantChemokine CXCL2Chemokines, CXCCxcl2 protein, ratI kappa B beta proteinI-kappa B ProteinsLipopolysaccharidesNF-kappa BNF-KappaB Inhibitor alphaNfkbia protein, ratPlatelet Activating FactorpyrrolidinePyrrolidinesRNA, MessengerTriazolesTumor Necrosis Factor-alpha

Identifiers

PMID16771850
PMCPMC1782278
OpenAlexW1993597798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.